Année
2025
Auteurs
DE POUVOURVILLE Gérard, Chouaid Christos, Marchal Clarisse, Apert Marion, Bensimon Lionel, Guimard Valérie, Née Mélanie, Belhassen Manon, Blay Jean-Yves
Abstract
Treatment landscape in metastatic lung cancer has progressed quickly over the last decade, mainly due to immunotherapies and targeted therapies. This study aimed to describe change in epidemiological data of patients with metastatic lung cancer. This study provides unpublished epidemiological data on metastatic lung cancer in France and confirms sex-differentiated trends in the rate of newly-diagnosed metastatic patients, already observed for all stages combined. A statistically significant decrease in the proportion of deaths among metastatic lung cancer patients is observed in both genders. These results underline the importance of ongoing investments in prevention and screening initiatives to reverse the incidence trends observed in women. Moreover, it highlights the criticality of therapeutic innovation in sustaining the increase in survival.
CHOUAID, C., MARCHAL, C., APERT, M., BENSIMON, L., GUIMARD, V., NÉE, M. … BLAY, J.Y. (2025). Epidemiology of metastatic lung cancer in France between 2013 and 2021: Observational study using the French claims database. Bulletin du Cancer, 112(2), pp. 166-177.